Wei Peu ZEN - 15 Dec 2023 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Director
Signature
Wei Peu Zen
Issuer symbol
EMMA
Transactions as of
15 Dec 2023
Transactions value $
$90,685
Form type
4
Filing time
19 Dec 2023, 19:40:45 UTC
Previous filing
20 Jan 2023
Next filing
05 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Other $1.09M +3.76M +373.17% $0.29 4.77M 15 Dec 2023 Direct F1
holding EMMA Common stock, $0.001 par value 1.27M 15 Dec 2023 By Profit Preview International Group Limited F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EMMA Convertible Promissory Note dated 2023-01-18 Other -$1M -2M -100% $0.50 0 18 Jan 2023 Common Stock 2M $0.50 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shown were issued in exchange for principal and accrued interest under the promissory note of the Issuer held by the reporting person referred to in footnote (2), below, which promissory note was surrendered by the reporting person for cancellation.
F2 Profit Preview International Group Limited is a Hong Kong limited company wholly owned by the Reporting Person and of which the Reporting Person is a director.
F3 The Convertible Promissory Note dated 2023-01-18 was surrendered to the Issuer for cancellation in exchange for the shares referred to in footnote (1), above.
F4 Represent shares previously issuable upon conversion of the Convertible Promissory Note.